LONDON & SEATTLE–(BUSINESS WIRE)– #InvestorConference–Tenpoint Therapeutics, Ltd. to Participate in Four Upcoming Investor Conferences
Category: Business
Tilak Healthcare Obtains Reimbursement for Odysight®, the First Remote Monitoring Solution in Ophthalmology, via the PECAN Progam
PARIS–(BUSINESS WIRE)–Tilak Healthcare, a pioneering company and leader in digital health for chronic eye disease monitoring, announces that it has received a positive opinion from the French National Health Authority (HAS) for the exceptional reimbu…
STAAR Surgical Board of Directors Reiterates Unanimous Recommendation that STAAR Stockholders Vote “FOR” the Alcon Merger Agreement on WHITE Proxy Card
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today provided the following statement in resp…
Broadwood Partners: Leading Advisory Firm Glass Lewis Urges STAAR Shareholders to Vote “AGAINST” Sale to Alcon
NEW YORK–(BUSINESS WIRE)–Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”) today announced that Glass, Lewis & Co., LLC (“Glass Lewis”), a leading independent proxy advisory firm, has recommended that the shareholders of STAAR Sur…
Howe Innovation Center at Perkins Hosts DisabilityTech Pitch Challenge With Mitsubishi Electric
WATERTOWN, Mass.–(BUSINESS WIRE)–On October 7, the Howe Innovation Center at Perkins School for the Blind hosted a DisabilityTech Pitch Challenge featuring nine start-up companies showcasing their assistive and adaptive technologies to create a more …
Horizon Surgical Systems Completes World’s First Robotic-Assisted Cataract Surgery
LOS ANGELES–(BUSINESS WIRE)–Horizon Surgical Systems (Horizon), a robotics company revolutionizing ophthalmic surgery through the application of robotics and artificial intelligence (AI), today announced the world’s first cataract surgery performed u…
Glaukos to Release Third Quarter 2025 Financial Results after Market Close on October 29
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release third…
GenSight Biologics Reports Cash Position as of September 30, 2025
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (“GenSight Biologics” or the “Company”) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for ret…
Sightview to Unveil New Design, User Experience at AAO 2025
DURHAM, N.C.–(BUSINESS WIRE)– #EHR–Sightview’s new UI brings workflow and efficiency enhancements, developed and tested with optometrists, ophthalmologists and opticians.
National Vision Launches 2025-2026 Scholarship Program, Spotlighting Technology’s Role in Access to Eye Care
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE), one of the largest optical retail companies in the United States, announced today that its annual scholarship program is open for entries, offering eligible optometry students …
Fuchs Endothelial Corneal Dystrophy Market Report 2025-2035: Epidemiology, Regulatory Landscape, Ongoing Clinical Trials, Market Dynamics, Patent Analysis – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Fuchs Endothelial Corneal Dystrophy Market – A Global and Regional Analysis: Focus on Treatment Method, End User, and Region – Analysis and Forecast, 2025-2035” report has been added to ResearchAndMarkets.com’s offering. T…
Presbyopia Market Analysis and Forecast Report 2025-2035 Featuring AbbVie, Eyenovia, Entod Pharma, Lenz Therapeutics, Orasis Pharmaceuticals, and Tenpoint Therapeutics – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Presbyopia Market – A Global and Regional Analysis: Focus on Country and Region – Analysis and Forecast, 2025-2035” report has been added to ResearchAndMarkets.com’s offering. The global presbyopia market is experiencing s…
EyeCare Partners to Showcase Optometric Expertise and Innovation at the American Academy of Optometry (AAO) Academy 2025 Boston
ST. LOUIS–(BUSINESS WIRE)–EyeCare Partners is proud to announce its participation in the American Academy of Optometry (AAO) Academy 2025 Boston.
ReadingGlasses.com and American Mensa Unveil The Mensa Collection: Brilliant Eyewear Inspired by History’s Brightest Minds
DALLAS–(BUSINESS WIRE)–ReadingGlasses.com, a premier online eyewear destination for stylish readers, prescription glasses and sunglasses, has partnered with American Mensa, the high IQ society, to debut The Mensa Collection, a limited-edition line of…
Samsara Vision Announces First Pseudophakic Surgery in the PERSPECTIVE Clinical Trial to Evaluate the Smaller-Incision New-Generation Implantable Miniature Telescope (SING IMT®) in Patients with Previous Cataract Surgery
FAR HILLS, N.J.–(BUSINESS WIRE)– #AMD–Samsara Vision Announces First Pseudophakic Surgery in the PERSPECTIVE Clinical Trial to evaluate SING IMT in Patients with Previous Cataract Surgery
Eye Health America Announces Jay Burkett as Chief Executive Officer; Mary Lou Parisi as Chief Growth Officer
GREENVILLE, S.C.–(BUSINESS WIRE)–Eye Health America announced today Jay Burkett has been named Chief Executive Officer. Mary Lou Parisi, co-CEO, was named Chief Growth Officer.
Broadwood Partners Issues Letter to STAAR Surgical’s Board Questioning Its Judgment in Proposed Sale to Alcon
NEW YORK–(BUSINESS WIRE)–Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”) today issued the following letter to the Board of Directors (the “Board”) of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA). Broadwood,…
STAAR Surgical: Independent Industry Analysts Recognize Merits of Alcon Merger, the Value It Provides, and the Downside Risks Facing STAAR on Standalone Basis
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today highlighted commentary from numerous independent i…
STAAR Surgical Addresses Broadwood Partners’ Flawed, Misleading, and Misinformed Claims
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today issued the following statement with respect to the…
Broadwood Partners Publishes Presentation Detailing Opposition to STAAR Surgical’s Sale to Alcon
NEW YORK–(BUSINESS WIRE)–Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”), holders of approximately 27.5% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), today announced that…